Legacy Advisors’s Dentsply Sirona XRAY Stock Holding History

Legacy Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-46	Closed	-$2K	–	437
2017 Q3	$2K	Buy	+46	New	+$2.73K	﹤0.01%	329

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Legacy Advisors's XRAY Position: Q4 2017 in Review

Legacy Advisors sold out of Dentsply Sirona (XRAY) in Q4 2017, closing a stake of 46 shares — an estimated $2K sold.

Legacy Advisors first reported a position in XRAY in Q3 2017 and held it in 1 quarter. The position peaked at $2K in Q3 2017. 570 funds tracked by Wall St. Rank hold XRAY as of Q4 2017.

Legacy Advisors reported no remaining Dentsply Sirona position as of Q4 2017 after selling out during the quarter.
Legacy Advisors sold 46 Dentsply Sirona shares in Q4 2017, an estimated $2K.
Legacy Advisors first reported a position in Dentsply Sirona in Q3 2017 and held it in 1 quarter.
Legacy Advisors's Dentsply Sirona position peaked at $2K in Q3 2017.
570 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2017.

Based on Legacy Advisors's 13F filing for Q4 2017, filed 26 Jan 2018.